NCT01035073View on ClinicalTrials.gov

Functional Change and Efficacy of Duloxetine in Patients With Co-Morbid Depression & Soft Tissue Discomfort Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Major Depressive DisorderSoft Tissue Discomfort SyndromePain
Interventions
DRUG

Duloxetine

30-60 mg daily for 8 weeks

Trial Locations (1)

19104-3309

Depression Research Unit, University of Pennsylvania School of Medicine, Philadelphia

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

University of Pennsylvania

OTHER

NCT01035073 - Functional Change and Efficacy of Duloxetine in Patients With Co-Morbid Depression & Soft Tissue Discomfort Syndrome | Biotech Hunter | Biotech Hunter